IL227540A0 - Injectible compositions comprising an nsaid and an antibiotic in a non-aqueous solvent and uses thereof - Google Patents

Injectible compositions comprising an nsaid and an antibiotic in a non-aqueous solvent and uses thereof

Info

Publication number
IL227540A0
IL227540A0 IL227540A IL22754013A IL227540A0 IL 227540 A0 IL227540 A0 IL 227540A0 IL 227540 A IL227540 A IL 227540A IL 22754013 A IL22754013 A IL 22754013A IL 227540 A0 IL227540 A0 IL 227540A0
Authority
IL
Israel
Prior art keywords
nsaid
antibiotic
aqueous solvent
injectible compositions
injectible
Prior art date
Application number
IL227540A
Other languages
Hebrew (he)
Other versions
IL227540A (en
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46515931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL227540(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of IL227540A0 publication Critical patent/IL227540A0/en
Publication of IL227540A publication Critical patent/IL227540A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL227540A 2011-01-20 2013-07-18 Injectible compositions comprising an nsaid and an antibiotic in a non-aqueous solvent and uses thereof IL227540A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ588686A NZ588686A (en) 2011-01-20 2011-01-20 Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland
PCT/NZ2012/000003 WO2012099479A1 (en) 2011-01-20 2012-01-20 Injectable compositions for mastitis comprising an nsaid and an antibiotic in a non-aqueous solvent

Publications (2)

Publication Number Publication Date
IL227540A0 true IL227540A0 (en) 2013-09-30
IL227540A IL227540A (en) 2017-12-31

Family

ID=46515931

Family Applications (1)

Application Number Title Priority Date Filing Date
IL227540A IL227540A (en) 2011-01-20 2013-07-18 Injectible compositions comprising an nsaid and an antibiotic in a non-aqueous solvent and uses thereof

Country Status (15)

Country Link
KR (1) KR101905173B1 (en)
CN (1) CN103327984B (en)
AU (1) AU2012207698A1 (en)
BR (1) BR112013018557B1 (en)
CL (1) CL2013002086A1 (en)
CO (1) CO6801732A2 (en)
CR (1) CR20130401A (en)
GT (1) GT201300182A (en)
IL (1) IL227540A (en)
MX (1) MX353876B (en)
NI (1) NI201300063A (en)
NZ (1) NZ588686A (en)
PE (1) PE20140035A1 (en)
WO (1) WO2012099479A1 (en)
ZA (1) ZA201305780B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2995297A1 (en) * 2014-09-09 2016-03-16 Ceva Sante Animale Parenteral compositions and uses thereof
AR102172A1 (en) 2015-10-05 2017-02-08 Química Luar S R L A BACTERICIDE AND VIRUCIDE PHARMACEUTICAL COMPOSITION
CN105663037A (en) * 2016-01-27 2016-06-15 成都乾坤动物药业有限公司 Amoxicillin solution as well as preparation method and application thereof
CN112472667B (en) * 2019-08-23 2022-11-15 北京欧博方医药科技有限公司 Retxib long-acting injection and preparation method and application thereof
CN111035614B (en) * 2019-12-20 2024-02-02 北京喜禽药业有限公司 High-content terramycin injection and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CN1297319C (en) * 2003-09-22 2007-01-31 王玉万 Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium
US20050148519A1 (en) 2003-10-29 2005-07-07 Murthy Yerramilli V.S. Salts of pharmacologically active compounds
DE102004025324A1 (en) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation for veterinary medicine, process for their preparation and their use

Also Published As

Publication number Publication date
NI201300063A (en) 2014-05-23
KR101905173B1 (en) 2018-11-28
ZA201305780B (en) 2014-04-30
CR20130401A (en) 2014-02-04
AU2012207698A1 (en) 2013-04-18
BR112013018557A2 (en) 2016-11-22
NZ588686A (en) 2013-07-26
CN103327984A (en) 2013-09-25
IL227540A (en) 2017-12-31
KR20140012646A (en) 2014-02-03
GT201300182A (en) 2014-07-28
WO2012099479A1 (en) 2012-07-26
BR112013018557B1 (en) 2021-11-03
MX353876B (en) 2018-02-01
PE20140035A1 (en) 2014-02-16
CL2013002086A1 (en) 2014-07-25
CN103327984B (en) 2016-08-17
CO6801732A2 (en) 2013-11-29
MX2013008407A (en) 2013-09-26

Similar Documents

Publication Publication Date Title
EP2661453A4 (en) Polymer compositions and methods
EP2707224A4 (en) Polymer compositions and methods
EP2736974A4 (en) Polymer compositions and methods
EP2601688A4 (en) Device components with surface-embedded additives and related manufacturing methods
EP2663635A4 (en) Microbial compositions and methods
ZA201403594B (en) Composition comprising a non-ionic surfactant and an ionic polymer
EP2707573B8 (en) Tip for degradation tool and tool comprising same
EP2601269A4 (en) Anti-settling compositions and methods for use
IL227540A0 (en) Injectible compositions comprising an nsaid and an antibiotic in a non-aqueous solvent and uses thereof
EP2760910A4 (en) Oxetane-containing compounds and compositions thereof
EP2672837A4 (en) Nutritional compositions and uses thereof
GB201106357D0 (en) Composition and uses thereof
EP2766357A4 (en) Meso-biliverdin compositions and methods
WO2013067576A9 (en) Methods for dealing in real property
EP2795333A4 (en) Pseudogenes and uses thereof
WO2012162108A9 (en) Boron-containing compositions and methods therefor
AU2011903104A0 (en) Composition And Uses Thereof
AU2011902984A0 (en) Compositions and their use
AU2011903981A0 (en) Improvements in exercise devices
GB201120470D0 (en) Compositions and uses thereof
AU2011900931A0 (en) Pharmaceutical compositions and use thereof
SG11201401075VA (en) Antibiotic composition and its uses
AU2011900032A0 (en) Retriever
GB201107454D0 (en) Compositions and uses
AU2012905095A0 (en) Compositions and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees